v3.26.3
Lease
9 Months Ended
Sep. 30, 2026
Leases [Abstract]  
Lease

4. Lease

 

On January 1, 2025, the Company assumed an office lease from Duraviva Pharma Inc. (“Duraviva”), a New York corporation under common control, through a lease assignment agreement. The lease term extends through August 31, 2026. On August 13, 2026, the Company executed a lease amendment extending the term through September 30, 2031. The Company classified the lease as an operating lease. Upon adoption of ASC 842, the Company recognized right-of-use asset and corresponding lease liability for its operating lease. The lease extension was accounted for under ASC 842 effective September 1, 2026, resulting in an additional right-of-use asset and lease liability of $295,558.

 

During the fourth quarter of 2025, the Company entered into lease agreements for three motor vehicles with non-cancelable lease terms ranging from 36 to 51 months.

 

The following summarizes information about the Company’s lease as of September 30, 2026 and December 31, 2025.

 

 Schedule of Lease

       
  

For the Three Months Ended

September 30,

 
   2026   2025 
Amount recognized in the income statements          
           
Operating lease expense  $40,278   $17,404 

 

       
  

For the Nine Months Ended

September 30,

 
   2026   2025 
Amount recognized in the income statements          
           
Operating lease expense  $120,216   $52,211 

 

 

   As of September 30, 2026   As of December 31, 2025 
         
Amount recognized in the balance sheets          
           
Right-of-use assets  $540,622   $352,616 
Operating lease liabilities   542,090    346,699 
           
Amount recognized in the income statements          
           
Cash paid for amounts included in the measurement of lease liabilities          
           
Operating lease expense  $114,430   $93,957 
           
Lease commitment          
           
2026  $38,343   $136,921 
2027   154,008    89,964 
2028   154,330    86,766 
2029   129,022    61,078 
2030   69,982    - 
Thereafter (2031)   53,704    - 
Total future minimum lease payments   599,389    374,729 
less imputed interest   (57,299)   (28,030)
Present value of lease liabilities  $542,090   $346,699 
           
Supplement information          
           
Discount rate   4.87%   5.47%
           
Remaining lease term   49 months     47 months